Plan Name | ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST |
Plan identification number | 337 |
Company Name: | ABBOTT LABORATORIES |
Employer identification number (EIN): | 360698440 |
NAIC Classification: | 325410 |
Additional information about ABBOTT LABORATORIES
Jurisdiction of Incorporation: | Texas Secretary of State |
Incorporation Date: | 1935-02-11 |
Company Identification Number: | 0000841506 |
Legal Registered Office Address: |
100 ABBOTT PARK RD C/O TAX DEPT D367 & A ABBOTT PARK United States of America (USA) 60064 |
More information about ABBOTT LABORATORIES
Plan id# | Filing Submission Date | Name of Administrator | Date Administrator Signed | Name of Company Sponsor | Date Sponsor Signed |
---|---|---|---|---|---|
337 | 2023-01-01 | ||||
337 | 2022-01-01 | ||||
337 | 2021-01-01 | ||||
337 | 2020-01-01 | ||||
337 | 2019-01-01 | ||||
337 | 2018-01-01 | ||||
337 | 2017-01-01 | 2018-10-13 | |||
337 | 2016-01-01 | 2017-10-14 | |||
337 | 2015-01-01 | 2016-10-14 | |||
337 | 2014-01-01 | MARY MORELAND | MARY MORELAND | 2015-10-14 | |
337 | 2013-01-01 | MARY MORELAND | MARY MORELAND | 2014-10-14 | |
337 | 2012-01-01 | MARY MORELAND | |||
337 | 2011-01-01 | 2012-10-09 | |||
337 | 2010-10-29 | 2011-10-12 |
Measure | Date | Value |
---|---|---|
2015: ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2015 401k membership | ||
Total of all active and inactive participants | 2015-01-01 | 0 |
2014: ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2014 401k membership | ||
Total of all active and inactive participants | 2014-01-01 | 0 |
2013: ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2013 401k membership | ||
Total of all active and inactive participants | 2013-01-01 | 0 |
2012: ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2012 401k membership | ||
Total of all active and inactive participants | 2012-01-01 | 0 |
2011: ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2011 401k membership | ||
Total of all active and inactive participants | 2011-01-01 | 0 |
Measure | Date | Value |
---|---|---|
2023 : ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2023 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2023-12-31 | $558,549,132 |
Total unrealized appreciation/depreciation of assets | 2023-12-31 | $558,549,132 |
Total transfer of assets to this plan | 2023-12-31 | $309,364,668 |
Total transfer of assets from this plan | 2023-12-31 | $251,545,796 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-12-31 | $37,792,676 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-12-31 | $31,572,265 |
Total income from all sources (including contributions) | 2023-12-31 | $1,007,355,973 |
Total loss/gain on sale of assets | 2023-12-31 | $71,430,247 |
Total of all expenses incurred | 2023-12-31 | $17,472,507 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2023-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2023-12-31 | $0 |
Value of total assets at end of year | 2023-12-31 | $7,545,240,611 |
Value of total assets at beginning of year | 2023-12-31 | $6,491,317,862 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2023-12-31 | $17,472,507 |
Total interest from all sources | 2023-12-31 | $53,720,222 |
Total dividends received (eg from common stock, registered investment company shares) | 2023-12-31 | $30,359,552 |
Total dividends received from registered investment company shares (eg mutual funds) | 2023-12-31 | $8,027,841 |
Assets. Corporate prefeered stocks other than exployer securities at end of year | 2023-12-31 | $2,719,166 |
Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2023-12-31 | $2,390,334 |
Were there any nonexempt tranactions with any party-in-interest | 2023-12-31 | No |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2023-12-31 | $21,497,435 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2023-12-31 | $17,092,086 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2023-12-31 | $37,792,676 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2023-12-31 | $31,572,265 |
Administrative expenses (other) incurred | 2023-12-31 | $745,162 |
Total non interest bearing cash at end of year | 2023-12-31 | $0 |
Total non interest bearing cash at beginning of year | 2023-12-31 | $4,876,864 |
Value of net income/loss | 2023-12-31 | $989,883,466 |
Value of net assets at end of year (total assets less liabilities) | 2023-12-31 | $7,507,447,935 |
Value of net assets at beginning of year (total assets less liabilities) | 2023-12-31 | $6,459,745,597 |
Were any loans by the plan or fixed income obligations due to the plan in default | 2023-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2023-12-31 | No |
Assets. partnership/joint venture interests at end of year | 2023-12-31 | $2,386,403,357 |
Assets. partnership/joint venture interests at beginning of year | 2023-12-31 | $2,213,502,819 |
Investment advisory and management fees | 2023-12-31 | $14,304,514 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2023-12-31 | $151,217,908 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2023-12-31 | $129,235,436 |
Interest earned on other investments | 2023-12-31 | $101,513 |
Income. Interest from US Government securities | 2023-12-31 | $2,149,829 |
Income. Interest from corporate debt instruments | 2023-12-31 | $49,875,888 |
Value of interest in common/collective trusts at end of year | 2023-12-31 | $1,880,363,537 |
Value of interest in common/collective trusts at beginning of year | 2023-12-31 | $1,574,490,038 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2023-12-31 | $1,150,059 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2023-12-31 | $596,554 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2023-12-31 | $596,554 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2023-12-31 | $1,592,992 |
Assets. Value of investments in 103.12 investment entities at end of year | 2023-12-31 | $305,460,348 |
Assets. Value of investments in 103.12 investment entities at beginning of year | 2023-12-31 | $311,853,870 |
Asset value of US Government securities at end of year | 2023-12-31 | $155,588,673 |
Asset value of US Government securities at beginning of year | 2023-12-31 | $133,244,891 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2023-12-31 | $10,909,630 |
Net investment gain or loss from common/collective trusts | 2023-12-31 | $285,735,712 |
Net gain/loss from 103.12 investment entities | 2023-12-31 | $-3,348,522 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2023-12-31 | Yes |
Income. Dividends from preferred stock | 2023-12-31 | $230,430 |
Income. Dividends from common stock | 2023-12-31 | $22,101,281 |
Asset. Corporate debt instrument preferred debt at end of year | 2023-12-31 | $43,487,955 |
Asset. Corporate debt instrument preferred debt at beginning of year | 2023-12-31 | $33,264,455 |
Asset. Corporate debt instrument debt (other) at end of year | 2023-12-31 | $777,828,344 |
Asset. Corporate debt instrument debt (other) at beginning of year | 2023-12-31 | $637,307,820 |
Assets. Corporate common stocks other than exployer securities at end of year | 2023-12-31 | $1,819,523,829 |
Assets. Corporate common stocks other than exployer securities at beginning of year | 2023-12-31 | $1,433,462,695 |
Did the plan have assets held for investment | 2023-12-31 | Yes |
Aggregate proceeds on sale of assets | 2023-12-31 | $1,281,240,004 |
Aggregate carrying amount (costs) on sale of assets | 2023-12-31 | $1,209,809,757 |
2022 : ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2022 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2022-12-31 | $-536,359,849 |
Total unrealized appreciation/depreciation of assets | 2022-12-31 | $-536,359,849 |
Total transfer of assets to this plan | 2022-12-31 | $311,577,077 |
Total transfer of assets from this plan | 2022-12-31 | $235,491,417 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $31,572,265 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $73,525,628 |
Total income from all sources (including contributions) | 2022-12-31 | $-916,519,324 |
Total loss/gain on sale of assets | 2022-12-31 | $-175,221,601 |
Total of all expenses incurred | 2022-12-31 | $16,547,358 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-12-31 | $0 |
Value of total assets at end of year | 2022-12-31 | $6,491,317,862 |
Value of total assets at beginning of year | 2022-12-31 | $7,390,252,247 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-12-31 | $16,547,358 |
Total interest from all sources | 2022-12-31 | $43,951,985 |
Total dividends received (eg from common stock, registered investment company shares) | 2022-12-31 | $26,712,285 |
Total dividends received from registered investment company shares (eg mutual funds) | 2022-12-31 | $6,717,540 |
Administrative expenses professional fees incurred | 2022-12-31 | $420,620 |
Assets. Corporate prefeered stocks other than exployer securities at end of year | 2022-12-31 | $2,390,334 |
Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2022-12-31 | $1,737,329 |
Were there any nonexempt tranactions with any party-in-interest | 2022-12-31 | No |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2022-12-31 | $17,092,086 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2022-12-31 | $50,883,755 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2022-12-31 | $31,572,265 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2022-12-31 | $73,525,628 |
Administrative expenses (other) incurred | 2022-12-31 | $1,496,171 |
Total non interest bearing cash at end of year | 2022-12-31 | $4,876,864 |
Total non interest bearing cash at beginning of year | 2022-12-31 | $76,712 |
Value of net income/loss | 2022-12-31 | $-933,066,682 |
Value of net assets at end of year (total assets less liabilities) | 2022-12-31 | $6,459,745,597 |
Value of net assets at beginning of year (total assets less liabilities) | 2022-12-31 | $7,316,726,619 |
Were any loans by the plan or fixed income obligations due to the plan in default | 2022-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2022-12-31 | No |
Assets. partnership/joint venture interests at end of year | 2022-12-31 | $2,213,502,819 |
Assets. partnership/joint venture interests at beginning of year | 2022-12-31 | $2,308,048,549 |
Investment advisory and management fees | 2022-12-31 | $14,630,567 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2022-12-31 | $129,235,436 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2022-12-31 | $157,271,387 |
Interest earned on other investments | 2022-12-31 | $251,763 |
Income. Interest from US Government securities | 2022-12-31 | $1,547,043 |
Income. Interest from corporate debt instruments | 2022-12-31 | $41,983,548 |
Value of interest in common/collective trusts at end of year | 2022-12-31 | $1,574,490,038 |
Value of interest in common/collective trusts at beginning of year | 2022-12-31 | $1,694,357,718 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2022-12-31 | $596,554 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2022-12-31 | $350,877 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2022-12-31 | $350,877 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2022-12-31 | $169,631 |
Assets. Value of investments in 103.12 investment entities at end of year | 2022-12-31 | $311,853,870 |
Assets. Value of investments in 103.12 investment entities at beginning of year | 2022-12-31 | $312,375,844 |
Asset value of US Government securities at end of year | 2022-12-31 | $133,244,891 |
Asset value of US Government securities at beginning of year | 2022-12-31 | $113,958,437 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2022-12-31 | $-12,460,144 |
Net investment gain or loss from common/collective trusts | 2022-12-31 | $-265,361,521 |
Net gain/loss from 103.12 investment entities | 2022-12-31 | $2,219,521 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2022-12-31 | Yes |
Income. Dividends from preferred stock | 2022-12-31 | $27,811 |
Income. Dividends from common stock | 2022-12-31 | $19,966,934 |
Asset. Corporate debt instrument preferred debt at end of year | 2022-12-31 | $33,264,455 |
Asset. Corporate debt instrument preferred debt at beginning of year | 2022-12-31 | $32,800,600 |
Asset. Corporate debt instrument debt (other) at end of year | 2022-12-31 | $637,307,820 |
Asset. Corporate debt instrument debt (other) at beginning of year | 2022-12-31 | $873,616,475 |
Assets. Corporate common stocks other than exployer securities at end of year | 2022-12-31 | $1,433,462,695 |
Assets. Corporate common stocks other than exployer securities at beginning of year | 2022-12-31 | $1,844,774,564 |
Did the plan have assets held for investment | 2022-12-31 | Yes |
Aggregate proceeds on sale of assets | 2022-12-31 | $1,484,328,154 |
Aggregate carrying amount (costs) on sale of assets | 2022-12-31 | $1,659,549,755 |
2021 : ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2021 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2021-12-31 | $526,254,340 |
Total unrealized appreciation/depreciation of assets | 2021-12-31 | $526,254,340 |
Total transfer of assets to this plan | 2021-12-31 | $318,302,699 |
Total transfer of assets from this plan | 2021-12-31 | $220,864,571 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $73,525,628 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $30,472,066 |
Total income from all sources (including contributions) | 2021-12-31 | $945,073,714 |
Total loss/gain on sale of assets | 2021-12-31 | $122,082,818 |
Total of all expenses incurred | 2021-12-31 | $17,392,097 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2021-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2021-12-31 | $0 |
Value of total assets at end of year | 2021-12-31 | $7,390,252,247 |
Value of total assets at beginning of year | 2021-12-31 | $6,322,078,940 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2021-12-31 | $17,392,097 |
Total interest from all sources | 2021-12-31 | $41,654,639 |
Total dividends received (eg from common stock, registered investment company shares) | 2021-12-31 | $22,595,664 |
Total dividends received from registered investment company shares (eg mutual funds) | 2021-12-31 | $5,847,262 |
Administrative expenses professional fees incurred | 2021-12-31 | $347,538 |
Assets. Corporate prefeered stocks other than exployer securities at end of year | 2021-12-31 | $1,737,329 |
Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2021-12-31 | $4,499,185 |
Were there any nonexempt tranactions with any party-in-interest | 2021-12-31 | No |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2021-12-31 | $50,883,755 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2021-12-31 | $28,426,946 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2021-12-31 | $73,525,628 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2021-12-31 | $30,472,066 |
Administrative expenses (other) incurred | 2021-12-31 | $987,249 |
Total non interest bearing cash at end of year | 2021-12-31 | $76,712 |
Total non interest bearing cash at beginning of year | 2021-12-31 | $41,778 |
Value of net income/loss | 2021-12-31 | $927,681,617 |
Value of net assets at end of year (total assets less liabilities) | 2021-12-31 | $7,316,726,619 |
Value of net assets at beginning of year (total assets less liabilities) | 2021-12-31 | $6,291,606,874 |
Were any loans by the plan or fixed income obligations due to the plan in default | 2021-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2021-12-31 | No |
Assets. partnership/joint venture interests at end of year | 2021-12-31 | $2,308,048,549 |
Assets. partnership/joint venture interests at beginning of year | 2021-12-31 | $1,797,482,520 |
Investment advisory and management fees | 2021-12-31 | $16,057,310 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2021-12-31 | $157,271,387 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2021-12-31 | $155,444,645 |
Interest earned on other investments | 2021-12-31 | $239,604 |
Income. Interest from US Government securities | 2021-12-31 | $1,168,126 |
Income. Interest from corporate debt instruments | 2021-12-31 | $40,167,174 |
Value of interest in common/collective trusts at end of year | 2021-12-31 | $1,694,357,718 |
Value of interest in common/collective trusts at beginning of year | 2021-12-31 | $1,727,117,475 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2021-12-31 | $350,877 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2021-12-31 | $1,337,025 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2021-12-31 | $1,337,025 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2021-12-31 | $79,735 |
Assets. Value of investments in 103.12 investment entities at end of year | 2021-12-31 | $312,375,844 |
Assets. Value of investments in 103.12 investment entities at beginning of year | 2021-12-31 | $243,001,374 |
Asset value of US Government securities at end of year | 2021-12-31 | $113,958,437 |
Asset value of US Government securities at beginning of year | 2021-12-31 | $104,454,190 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2021-12-31 | $-638,670 |
Net investment gain or loss from common/collective trusts | 2021-12-31 | $215,498,571 |
Net gain/loss from 103.12 investment entities | 2021-12-31 | $17,626,352 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2021-12-31 | Yes |
Income. Dividends from preferred stock | 2021-12-31 | $100,158 |
Income. Dividends from common stock | 2021-12-31 | $16,648,244 |
Asset. Corporate debt instrument preferred debt at end of year | 2021-12-31 | $32,800,600 |
Asset. Corporate debt instrument preferred debt at beginning of year | 2021-12-31 | $17,465,110 |
Asset. Corporate debt instrument debt (other) at end of year | 2021-12-31 | $873,616,475 |
Asset. Corporate debt instrument debt (other) at beginning of year | 2021-12-31 | $646,458,119 |
Assets. Corporate common stocks other than exployer securities at end of year | 2021-12-31 | $1,844,774,564 |
Assets. Corporate common stocks other than exployer securities at beginning of year | 2021-12-31 | $1,596,350,573 |
Did the plan have assets held for investment | 2021-12-31 | Yes |
Aggregate proceeds on sale of assets | 2021-12-31 | $1,846,034,836 |
Aggregate carrying amount (costs) on sale of assets | 2021-12-31 | $1,723,952,018 |
2020 : ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2020 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2020-12-31 | $571,309,574 |
Total unrealized appreciation/depreciation of assets | 2020-12-31 | $571,309,574 |
Total transfer of assets to this plan | 2020-12-31 | $296,663,074 |
Total transfer of assets from this plan | 2020-12-31 | $204,808,834 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $30,472,066 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $15,344,842 |
Total income from all sources (including contributions) | 2020-12-31 | $845,009,208 |
Total loss/gain on sale of assets | 2020-12-31 | $24,006,565 |
Total of all expenses incurred | 2020-12-31 | $12,849,024 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2020-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2020-12-31 | $0 |
Value of total assets at end of year | 2020-12-31 | $6,322,078,940 |
Value of total assets at beginning of year | 2020-12-31 | $5,382,937,292 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2020-12-31 | $12,849,024 |
Total interest from all sources | 2020-12-31 | $36,863,799 |
Total dividends received (eg from common stock, registered investment company shares) | 2020-12-31 | $21,597,612 |
Total dividends received from registered investment company shares (eg mutual funds) | 2020-12-31 | $4,915,962 |
Administrative expenses professional fees incurred | 2020-12-31 | $381,176 |
Assets. Corporate prefeered stocks other than exployer securities at end of year | 2020-12-31 | $4,499,185 |
Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2020-12-31 | $3,528,170 |
Were there any nonexempt tranactions with any party-in-interest | 2020-12-31 | No |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2020-12-31 | $28,426,946 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2020-12-31 | $21,688,684 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2020-12-31 | $30,472,066 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2020-12-31 | $15,344,842 |
Administrative expenses (other) incurred | 2020-12-31 | $1,713,829 |
Total non interest bearing cash at end of year | 2020-12-31 | $41,778 |
Total non interest bearing cash at beginning of year | 2020-12-31 | $110,421 |
Value of net income/loss | 2020-12-31 | $832,160,184 |
Value of net assets at end of year (total assets less liabilities) | 2020-12-31 | $6,291,606,874 |
Value of net assets at beginning of year (total assets less liabilities) | 2020-12-31 | $5,367,592,450 |
Were any loans by the plan or fixed income obligations due to the plan in default | 2020-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2020-12-31 | No |
Assets. partnership/joint venture interests at end of year | 2020-12-31 | $1,797,482,520 |
Assets. partnership/joint venture interests at beginning of year | 2020-12-31 | $1,563,985,295 |
Investment advisory and management fees | 2020-12-31 | $10,754,019 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2020-12-31 | $155,444,645 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2020-12-31 | $156,461,773 |
Interest earned on other investments | 2020-12-31 | $176,040 |
Income. Interest from US Government securities | 2020-12-31 | $2,178,562 |
Income. Interest from corporate debt instruments | 2020-12-31 | $33,819,229 |
Value of interest in common/collective trusts at end of year | 2020-12-31 | $1,687,761,298 |
Value of interest in common/collective trusts at beginning of year | 2020-12-31 | $1,508,543,802 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2020-12-31 | $40,693,202 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2020-12-31 | $38,091,616 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2020-12-31 | $38,091,616 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2020-12-31 | $689,968 |
Assets. Value of investments in 103.12 investment entities at end of year | 2020-12-31 | $243,001,374 |
Assets. Value of investments in 103.12 investment entities at beginning of year | 2020-12-31 | $246,161,555 |
Asset value of US Government securities at end of year | 2020-12-31 | $104,454,190 |
Asset value of US Government securities at beginning of year | 2020-12-31 | $150,311,193 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2020-12-31 | $-1,996,261 |
Net investment gain or loss from common/collective trusts | 2020-12-31 | $202,074,749 |
Net gain/loss from 103.12 investment entities | 2020-12-31 | $-8,846,830 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2020-12-31 | Yes |
Income. Dividends from preferred stock | 2020-12-31 | $135,934 |
Income. Dividends from common stock | 2020-12-31 | $16,545,716 |
Asset. Corporate debt instrument preferred debt at end of year | 2020-12-31 | $17,465,110 |
Asset. Corporate debt instrument preferred debt at beginning of year | 2020-12-31 | $17,429,494 |
Asset. Corporate debt instrument debt (other) at end of year | 2020-12-31 | $646,458,119 |
Asset. Corporate debt instrument debt (other) at beginning of year | 2020-12-31 | $475,417,992 |
Assets. Corporate common stocks other than exployer securities at end of year | 2020-12-31 | $1,596,350,573 |
Assets. Corporate common stocks other than exployer securities at beginning of year | 2020-12-31 | $1,201,207,297 |
Did the plan have assets held for investment | 2020-12-31 | Yes |
Aggregate proceeds on sale of assets | 2020-12-31 | $1,817,296,359 |
Aggregate carrying amount (costs) on sale of assets | 2020-12-31 | $1,793,289,794 |
2019 : ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2019 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2019-12-31 | $404,642,641 |
Unrealized appreciation/depreciation of other (non real estate) assets | 2019-12-31 | $404,642,641 |
Total unrealized appreciation/depreciation of assets | 2019-12-31 | $404,642,641 |
Total unrealized appreciation/depreciation of assets | 2019-12-31 | $404,642,641 |
Total transfer of assets to this plan | 2019-12-31 | $296,734,342 |
Total transfer of assets to this plan | 2019-12-31 | $296,734,342 |
Total transfer of assets from this plan | 2019-12-31 | $194,639,700 |
Total transfer of assets from this plan | 2019-12-31 | $194,639,700 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $15,344,842 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $15,344,842 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $477,823,192 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $477,823,192 |
Total income from all sources (including contributions) | 2019-12-31 | $904,226,384 |
Total income from all sources (including contributions) | 2019-12-31 | $904,226,384 |
Total loss/gain on sale of assets | 2019-12-31 | $81,115,111 |
Total loss/gain on sale of assets | 2019-12-31 | $81,115,111 |
Total of all expenses incurred | 2019-12-31 | $11,618,970 |
Total of all expenses incurred | 2019-12-31 | $11,618,970 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2019-12-31 | $0 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2019-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2019-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2019-12-31 | $0 |
Value of total assets at end of year | 2019-12-31 | $5,382,937,292 |
Value of total assets at end of year | 2019-12-31 | $5,382,937,292 |
Value of total assets at beginning of year | 2019-12-31 | $4,850,713,586 |
Value of total assets at beginning of year | 2019-12-31 | $4,850,713,586 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2019-12-31 | $11,618,970 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2019-12-31 | $11,618,970 |
Total interest from all sources | 2019-12-31 | $29,837,094 |
Total interest from all sources | 2019-12-31 | $29,837,094 |
Total dividends received (eg from common stock, registered investment company shares) | 2019-12-31 | $20,716,649 |
Total dividends received (eg from common stock, registered investment company shares) | 2019-12-31 | $20,716,649 |
Total dividends received from registered investment company shares (eg mutual funds) | 2019-12-31 | $6,077,304 |
Total dividends received from registered investment company shares (eg mutual funds) | 2019-12-31 | $6,077,304 |
Administrative expenses professional fees incurred | 2019-12-31 | $390,360 |
Administrative expenses professional fees incurred | 2019-12-31 | $390,360 |
Assets. Corporate prefeered stocks other than exployer securities at end of year | 2019-12-31 | $3,528,170 |
Assets. Corporate prefeered stocks other than exployer securities at end of year | 2019-12-31 | $3,528,170 |
Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2019-12-31 | $2,612,349 |
Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2019-12-31 | $2,612,349 |
Were there any nonexempt tranactions with any party-in-interest | 2019-12-31 | No |
Assets. Other investments not covered elsewhere at end of year | 2019-12-31 | $0 |
Assets. Other investments not covered elsewhere at end of year | 2019-12-31 | $0 |
Assets. Other investments not covered elsewhere at beginning of year | 2019-12-31 | $50,000 |
Assets. Other investments not covered elsewhere at beginning of year | 2019-12-31 | $50,000 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2019-12-31 | $21,688,684 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2019-12-31 | $21,688,684 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2019-12-31 | $39,329,255 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2019-12-31 | $39,329,255 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2019-12-31 | $15,344,842 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2019-12-31 | $15,344,842 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2019-12-31 | $477,823,192 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2019-12-31 | $477,823,192 |
Administrative expenses (other) incurred | 2019-12-31 | $2,245,095 |
Administrative expenses (other) incurred | 2019-12-31 | $2,245,095 |
Total non interest bearing cash at end of year | 2019-12-31 | $110,421 |
Total non interest bearing cash at end of year | 2019-12-31 | $110,421 |
Total non interest bearing cash at beginning of year | 2019-12-31 | $70,576 |
Total non interest bearing cash at beginning of year | 2019-12-31 | $70,576 |
Value of net income/loss | 2019-12-31 | $892,607,414 |
Value of net income/loss | 2019-12-31 | $892,607,414 |
Value of net assets at end of year (total assets less liabilities) | 2019-12-31 | $5,367,592,450 |
Value of net assets at end of year (total assets less liabilities) | 2019-12-31 | $5,367,592,450 |
Value of net assets at beginning of year (total assets less liabilities) | 2019-12-31 | $4,372,890,394 |
Value of net assets at beginning of year (total assets less liabilities) | 2019-12-31 | $4,372,890,394 |
Were any loans by the plan or fixed income obligations due to the plan in default | 2019-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2019-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2019-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2019-12-31 | No |
Assets. partnership/joint venture interests at end of year | 2019-12-31 | $1,563,985,295 |
Assets. partnership/joint venture interests at end of year | 2019-12-31 | $1,563,985,295 |
Assets. partnership/joint venture interests at beginning of year | 2019-12-31 | $1,318,023,188 |
Assets. partnership/joint venture interests at beginning of year | 2019-12-31 | $1,318,023,188 |
Investment advisory and management fees | 2019-12-31 | $8,983,515 |
Investment advisory and management fees | 2019-12-31 | $8,983,515 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2019-12-31 | $156,461,773 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2019-12-31 | $156,461,773 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2019-12-31 | $233,453,163 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2019-12-31 | $233,453,163 |
Interest earned on other investments | 2019-12-31 | $637,385 |
Interest earned on other investments | 2019-12-31 | $637,385 |
Income. Interest from US Government securities | 2019-12-31 | $3,632,398 |
Income. Interest from US Government securities | 2019-12-31 | $3,632,398 |
Income. Interest from corporate debt instruments | 2019-12-31 | $24,816,675 |
Income. Interest from corporate debt instruments | 2019-12-31 | $24,816,675 |
Value of interest in common/collective trusts at end of year | 2019-12-31 | $1,508,543,802 |
Value of interest in common/collective trusts at end of year | 2019-12-31 | $1,508,543,802 |
Value of interest in common/collective trusts at beginning of year | 2019-12-31 | $1,602,871,567 |
Value of interest in common/collective trusts at beginning of year | 2019-12-31 | $1,602,871,567 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2019-12-31 | $38,091,616 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2019-12-31 | $38,091,616 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2019-12-31 | $10,103,313 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2019-12-31 | $10,103,313 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2019-12-31 | $10,103,313 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2019-12-31 | $10,103,313 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2019-12-31 | $750,636 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2019-12-31 | $750,636 |
Assets. Value of investments in 103.12 investment entities at end of year | 2019-12-31 | $246,161,555 |
Assets. Value of investments in 103.12 investment entities at end of year | 2019-12-31 | $246,161,555 |
Assets. Value of investments in 103.12 investment entities at beginning of year | 2019-12-31 | $271,826,075 |
Assets. Value of investments in 103.12 investment entities at beginning of year | 2019-12-31 | $271,826,075 |
Asset value of US Government securities at end of year | 2019-12-31 | $150,311,193 |
Asset value of US Government securities at end of year | 2019-12-31 | $150,311,193 |
Asset value of US Government securities at beginning of year | 2019-12-31 | $137,446,555 |
Asset value of US Government securities at beginning of year | 2019-12-31 | $137,446,555 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2019-12-31 | $9,319,090 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2019-12-31 | $9,319,090 |
Net investment gain or loss from common/collective trusts | 2019-12-31 | $340,653,368 |
Net investment gain or loss from common/collective trusts | 2019-12-31 | $340,653,368 |
Net gain/loss from 103.12 investment entities | 2019-12-31 | $17,942,431 |
Net gain/loss from 103.12 investment entities | 2019-12-31 | $17,942,431 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2019-12-31 | Yes |
Income. Dividends from preferred stock | 2019-12-31 | $143,272 |
Income. Dividends from preferred stock | 2019-12-31 | $143,272 |
Income. Dividends from common stock | 2019-12-31 | $14,496,073 |
Income. Dividends from common stock | 2019-12-31 | $14,496,073 |
Asset. Corporate debt instrument preferred debt at end of year | 2019-12-31 | $17,429,494 |
Asset. Corporate debt instrument preferred debt at end of year | 2019-12-31 | $17,429,494 |
Asset. Corporate debt instrument preferred debt at beginning of year | 2019-12-31 | $23,130,521 |
Asset. Corporate debt instrument preferred debt at beginning of year | 2019-12-31 | $23,130,521 |
Asset. Corporate debt instrument debt (other) at end of year | 2019-12-31 | $475,417,992 |
Asset. Corporate debt instrument debt (other) at end of year | 2019-12-31 | $475,417,992 |
Asset. Corporate debt instrument debt (other) at beginning of year | 2019-12-31 | $393,590,676 |
Asset. Corporate debt instrument debt (other) at beginning of year | 2019-12-31 | $393,590,676 |
Assets. Corporate common stocks other than exployer securities at end of year | 2019-12-31 | $1,201,207,297 |
Assets. Corporate common stocks other than exployer securities at end of year | 2019-12-31 | $1,201,207,297 |
Assets. Corporate common stocks other than exployer securities at beginning of year | 2019-12-31 | $818,206,348 |
Assets. Corporate common stocks other than exployer securities at beginning of year | 2019-12-31 | $818,206,348 |
Did the plan have assets held for investment | 2019-12-31 | Yes |
Aggregate proceeds on sale of assets | 2019-12-31 | $1,217,204,161 |
Aggregate proceeds on sale of assets | 2019-12-31 | $1,217,204,161 |
Aggregate carrying amount (costs) on sale of assets | 2019-12-31 | $1,136,089,050 |
Aggregate carrying amount (costs) on sale of assets | 2019-12-31 | $1,136,089,050 |
2018 : ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2018 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2018-12-31 | $-211,668,765 |
Total unrealized appreciation/depreciation of assets | 2018-12-31 | $-211,668,765 |
Total transfer of assets to this plan | 2018-12-31 | $30,498,920 |
Total transfer of assets from this plan | 2018-12-31 | $175,407,825 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2018-12-31 | $477,823,192 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2018-12-31 | $38,022,684 |
Total income from all sources (including contributions) | 2018-12-31 | $-253,315,352 |
Total loss/gain on sale of assets | 2018-12-31 | $28,288,182 |
Total of all expenses incurred | 2018-12-31 | $11,711,070 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2018-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2018-12-31 | $0 |
Value of total assets at end of year | 2018-12-31 | $4,850,713,586 |
Value of total assets at beginning of year | 2018-12-31 | $4,820,848,405 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2018-12-31 | $11,711,070 |
Total interest from all sources | 2018-12-31 | $23,483,634 |
Total dividends received (eg from common stock, registered investment company shares) | 2018-12-31 | $21,531,121 |
Total dividends received from registered investment company shares (eg mutual funds) | 2018-12-31 | $8,254,181 |
Administrative expenses professional fees incurred | 2018-12-31 | $458,289 |
Assets. Corporate prefeered stocks other than exployer securities at end of year | 2018-12-31 | $2,612,349 |
Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2018-12-31 | $2,076,765 |
Were there any nonexempt tranactions with any party-in-interest | 2018-12-31 | No |
Assets. Other investments not covered elsewhere at end of year | 2018-12-31 | $50,000 |
Assets. Other investments not covered elsewhere at beginning of year | 2018-12-31 | $0 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2018-12-31 | $39,329,255 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2018-12-31 | $81,672,017 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2018-12-31 | $477,823,192 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2018-12-31 | $38,022,684 |
Administrative expenses (other) incurred | 2018-12-31 | $603,811 |
Total non interest bearing cash at end of year | 2018-12-31 | $70,576 |
Total non interest bearing cash at beginning of year | 2018-12-31 | $47,843 |
Value of net income/loss | 2018-12-31 | $-265,026,422 |
Value of net assets at end of year (total assets less liabilities) | 2018-12-31 | $4,372,890,394 |
Value of net assets at beginning of year (total assets less liabilities) | 2018-12-31 | $4,782,825,721 |
Were any loans by the plan or fixed income obligations due to the plan in default | 2018-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2018-12-31 | No |
Assets. partnership/joint venture interests at end of year | 2018-12-31 | $1,318,023,188 |
Assets. partnership/joint venture interests at beginning of year | 2018-12-31 | $1,272,717,217 |
Investment advisory and management fees | 2018-12-31 | $10,648,970 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2018-12-31 | $233,453,163 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2018-12-31 | $266,367,580 |
Interest earned on other investments | 2018-12-31 | $786,233 |
Income. Interest from US Government securities | 2018-12-31 | $3,244,335 |
Income. Interest from corporate debt instruments | 2018-12-31 | $19,045,017 |
Value of interest in common/collective trusts at end of year | 2018-12-31 | $1,602,871,567 |
Value of interest in common/collective trusts at beginning of year | 2018-12-31 | $1,416,843,229 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2018-12-31 | $10,103,313 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2018-12-31 | $34,479,504 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2018-12-31 | $34,479,504 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2018-12-31 | $408,049 |
Assets. Value of investments in 103.12 investment entities at end of year | 2018-12-31 | $271,826,075 |
Assets. Value of investments in 103.12 investment entities at beginning of year | 2018-12-31 | $380,523,643 |
Asset value of US Government securities at end of year | 2018-12-31 | $137,446,555 |
Asset value of US Government securities at beginning of year | 2018-12-31 | $99,326,817 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2018-12-31 | $-13,992,550 |
Net investment gain or loss from common/collective trusts | 2018-12-31 | $-107,738,654 |
Net gain/loss from 103.12 investment entities | 2018-12-31 | $6,781,680 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2018-12-31 | Yes |
Income. Dividends from preferred stock | 2018-12-31 | $117,638 |
Income. Dividends from common stock | 2018-12-31 | $13,159,302 |
Asset. Corporate debt instrument preferred debt at end of year | 2018-12-31 | $23,130,521 |
Asset. Corporate debt instrument preferred debt at beginning of year | 2018-12-31 | $25,694,739 |
Asset. Corporate debt instrument debt (other) at end of year | 2018-12-31 | $393,590,676 |
Asset. Corporate debt instrument debt (other) at beginning of year | 2018-12-31 | $256,762,694 |
Assets. Corporate common stocks other than exployer securities at end of year | 2018-12-31 | $818,206,348 |
Assets. Corporate common stocks other than exployer securities at beginning of year | 2018-12-31 | $984,336,357 |
Did the plan have assets held for investment | 2018-12-31 | Yes |
Aggregate proceeds on sale of assets | 2018-12-31 | $1,392,589,359 |
Aggregate carrying amount (costs) on sale of assets | 2018-12-31 | $1,364,301,177 |
2017 : ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2017 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2017-12-31 | $347,865,303 |
Total unrealized appreciation/depreciation of assets | 2017-12-31 | $347,865,303 |
Total transfer of assets to this plan | 2017-12-31 | $562,381,014 |
Total transfer of assets from this plan | 2017-12-31 | $165,367,703 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2017-12-31 | $38,022,684 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2017-12-31 | $37,022,425 |
Total income from all sources (including contributions) | 2017-12-31 | $662,209,164 |
Total loss/gain on sale of assets | 2017-12-31 | $44,294,826 |
Total of all expenses incurred | 2017-12-31 | $11,244,624 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2017-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2017-12-31 | $0 |
Value of total assets at end of year | 2017-12-31 | $4,820,848,405 |
Value of total assets at beginning of year | 2017-12-31 | $3,771,870,295 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2017-12-31 | $11,244,624 |
Total interest from all sources | 2017-12-31 | $15,922,805 |
Total dividends received (eg from common stock, registered investment company shares) | 2017-12-31 | $19,073,404 |
Total dividends received from registered investment company shares (eg mutual funds) | 2017-12-31 | $7,527,841 |
Administrative expenses professional fees incurred | 2017-12-31 | $1,009,164 |
Assets. Corporate prefeered stocks other than exployer securities at end of year | 2017-12-31 | $2,076,765 |
Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2017-12-31 | $2,536,238 |
Were there any nonexempt tranactions with any party-in-interest | 2017-12-31 | No |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2017-12-31 | $81,672,017 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2017-12-31 | $34,939,043 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2017-12-31 | $38,022,684 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2017-12-31 | $37,022,425 |
Administrative expenses (other) incurred | 2017-12-31 | $661,359 |
Total non interest bearing cash at end of year | 2017-12-31 | $47,843 |
Total non interest bearing cash at beginning of year | 2017-12-31 | $0 |
Value of net income/loss | 2017-12-31 | $650,964,540 |
Value of net assets at end of year (total assets less liabilities) | 2017-12-31 | $4,782,825,721 |
Value of net assets at beginning of year (total assets less liabilities) | 2017-12-31 | $3,734,847,870 |
Were any loans by the plan or fixed income obligations due to the plan in default | 2017-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2017-12-31 | No |
Assets. partnership/joint venture interests at end of year | 2017-12-31 | $1,272,717,217 |
Assets. partnership/joint venture interests at beginning of year | 2017-12-31 | $1,046,347,675 |
Investment advisory and management fees | 2017-12-31 | $9,574,101 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2017-12-31 | $266,367,580 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2017-12-31 | $263,496,721 |
Interest earned on other investments | 2017-12-31 | $653,042 |
Income. Interest from US Government securities | 2017-12-31 | $2,333,856 |
Income. Interest from corporate debt instruments | 2017-12-31 | $12,702,152 |
Value of interest in common/collective trusts at end of year | 2017-12-31 | $1,416,843,229 |
Value of interest in common/collective trusts at beginning of year | 2017-12-31 | $903,489,759 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2017-12-31 | $34,479,504 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2017-12-31 | $17,790,109 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2017-12-31 | $17,790,109 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2017-12-31 | $233,755 |
Assets. Value of investments in 103.12 investment entities at end of year | 2017-12-31 | $380,523,643 |
Assets. Value of investments in 103.12 investment entities at beginning of year | 2017-12-31 | $413,581,361 |
Asset value of US Government securities at end of year | 2017-12-31 | $99,326,817 |
Asset value of US Government securities at beginning of year | 2017-12-31 | $84,248,869 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2017-12-31 | $25,187,133 |
Net investment gain or loss from common/collective trusts | 2017-12-31 | $194,123,104 |
Net gain/loss from 103.12 investment entities | 2017-12-31 | $15,742,589 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2017-12-31 | Yes |
Income. Dividends from preferred stock | 2017-12-31 | $127,672 |
Income. Dividends from common stock | 2017-12-31 | $11,417,891 |
Asset. Corporate debt instrument preferred debt at end of year | 2017-12-31 | $25,694,739 |
Asset. Corporate debt instrument preferred debt at beginning of year | 2017-12-31 | $22,816,795 |
Asset. Corporate debt instrument debt (other) at end of year | 2017-12-31 | $256,762,694 |
Asset. Corporate debt instrument debt (other) at beginning of year | 2017-12-31 | $216,054,634 |
Assets. Corporate common stocks other than exployer securities at end of year | 2017-12-31 | $984,336,357 |
Assets. Corporate common stocks other than exployer securities at beginning of year | 2017-12-31 | $766,569,091 |
Did the plan have assets held for investment | 2017-12-31 | Yes |
Aggregate proceeds on sale of assets | 2017-12-31 | $761,598,805 |
Aggregate carrying amount (costs) on sale of assets | 2017-12-31 | $717,303,979 |
2016 : ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2016 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2016-12-31 | $82,336,397 |
Total unrealized appreciation/depreciation of assets | 2016-12-31 | $82,336,397 |
Total transfer of assets to this plan | 2016-12-31 | $495,042,547 |
Total transfer of assets from this plan | 2016-12-31 | $141,026,006 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2016-12-31 | $37,022,425 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2016-12-31 | $3,345,425 |
Total income from all sources (including contributions) | 2016-12-31 | $256,597,833 |
Total loss/gain on sale of assets | 2016-12-31 | $12,064,746 |
Total of all expenses incurred | 2016-12-31 | $14,210,974 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2016-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2016-12-31 | $0 |
Value of total assets at end of year | 2016-12-31 | $3,771,870,295 |
Value of total assets at beginning of year | 2016-12-31 | $3,141,789,895 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2016-12-31 | $14,210,974 |
Total interest from all sources | 2016-12-31 | $26,737,880 |
Total dividends received (eg from common stock, registered investment company shares) | 2016-12-31 | $16,622,726 |
Total dividends received from registered investment company shares (eg mutual funds) | 2016-12-31 | $6,477,677 |
Administrative expenses professional fees incurred | 2016-12-31 | $274,195 |
Assets. Corporate prefeered stocks other than exployer securities at end of year | 2016-12-31 | $2,536,238 |
Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2016-12-31 | $580,959 |
Were there any nonexempt tranactions with any party-in-interest | 2016-12-31 | No |
Assets. Other investments not covered elsewhere at end of year | 2016-12-31 | $0 |
Assets. Other investments not covered elsewhere at beginning of year | 2016-12-31 | $19,109,435 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2016-12-31 | $34,939,043 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2016-12-31 | $6,444,978 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2016-12-31 | $37,022,425 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2016-12-31 | $3,345,425 |
Administrative expenses (other) incurred | 2016-12-31 | $8,397,015 |
Value of net income/loss | 2016-12-31 | $242,386,859 |
Value of net assets at end of year (total assets less liabilities) | 2016-12-31 | $3,734,847,870 |
Value of net assets at beginning of year (total assets less liabilities) | 2016-12-31 | $3,138,444,470 |
Were any loans by the plan or fixed income obligations due to the plan in default | 2016-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2016-12-31 | No |
Assets. partnership/joint venture interests at end of year | 2016-12-31 | $1,046,347,675 |
Assets. partnership/joint venture interests at beginning of year | 2016-12-31 | $822,452,018 |
Investment advisory and management fees | 2016-12-31 | $5,539,764 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2016-12-31 | $263,496,721 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2016-12-31 | $223,102,101 |
Interest earned on other investments | 2016-12-31 | $13,132,712 |
Income. Interest from US Government securities | 2016-12-31 | $1,754,320 |
Income. Interest from corporate debt instruments | 2016-12-31 | $11,743,811 |
Value of interest in common/collective trusts at end of year | 2016-12-31 | $903,489,759 |
Value of interest in common/collective trusts at beginning of year | 2016-12-31 | $991,810,562 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2016-12-31 | $17,790,109 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2016-12-31 | $7,884,741 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2016-12-31 | $7,884,741 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2016-12-31 | $107,037 |
Assets. Value of investments in 103.12 investment entities at end of year | 2016-12-31 | $413,581,361 |
Assets. Value of investments in 103.12 investment entities at beginning of year | 2016-12-31 | $177,276,101 |
Asset value of US Government securities at end of year | 2016-12-31 | $84,248,869 |
Asset value of US Government securities at beginning of year | 2016-12-31 | $53,158,846 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2016-12-31 | $7,656,464 |
Net investment gain or loss from common/collective trusts | 2016-12-31 | $89,846,507 |
Net gain/loss from 103.12 investment entities | 2016-12-31 | $21,333,113 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2016-12-31 | Yes |
Income. Dividends from preferred stock | 2016-12-31 | $88,479 |
Income. Dividends from common stock | 2016-12-31 | $10,056,570 |
Asset. Corporate debt instrument preferred debt at end of year | 2016-12-31 | $22,816,795 |
Asset. Corporate debt instrument preferred debt at beginning of year | 2016-12-31 | $21,167,857 |
Asset. Corporate debt instrument debt (other) at end of year | 2016-12-31 | $216,054,634 |
Asset. Corporate debt instrument debt (other) at beginning of year | 2016-12-31 | $164,051,944 |
Assets. Corporate common stocks other than exployer securities at end of year | 2016-12-31 | $766,569,091 |
Assets. Corporate common stocks other than exployer securities at beginning of year | 2016-12-31 | $654,750,353 |
Did the plan have assets held for investment | 2016-12-31 | Yes |
Aggregate proceeds on sale of assets | 2016-12-31 | $489,852,926 |
Aggregate carrying amount (costs) on sale of assets | 2016-12-31 | $477,788,180 |
2015 : ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2015 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2015-12-31 | $-41,448,919 |
Total unrealized appreciation/depreciation of assets | 2015-12-31 | $-41,448,919 |
Total transfer of assets to this plan | 2015-12-31 | $502,565,789 |
Total transfer of assets from this plan | 2015-12-31 | $112,400,105 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2015-12-31 | $3,345,425 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2015-12-31 | $22,677,313 |
Total income from all sources (including contributions) | 2015-12-31 | $-54,188,152 |
Total loss/gain on sale of assets | 2015-12-31 | $2,073,846 |
Total of all expenses incurred | 2015-12-31 | $9,439,561 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2015-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2015-12-31 | $0 |
Value of total assets at end of year | 2015-12-31 | $3,141,789,895 |
Value of total assets at beginning of year | 2015-12-31 | $2,834,583,812 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2015-12-31 | $9,439,561 |
Total interest from all sources | 2015-12-31 | $11,820,862 |
Total dividends received (eg from common stock, registered investment company shares) | 2015-12-31 | $16,886,777 |
Total dividends received from registered investment company shares (eg mutual funds) | 2015-12-31 | $9,452,047 |
Administrative expenses professional fees incurred | 2015-12-31 | $151,678 |
Assets. Corporate prefeered stocks other than exployer securities at end of year | 2015-12-31 | $580,959 |
Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2015-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2015-12-31 | No |
Assets. Other investments not covered elsewhere at end of year | 2015-12-31 | $19,109,435 |
Assets. Other investments not covered elsewhere at beginning of year | 2015-12-31 | $533,777,805 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2015-12-31 | $6,444,978 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2015-12-31 | $38,360,648 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2015-12-31 | $3,345,425 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2015-12-31 | $22,677,313 |
Administrative expenses (other) incurred | 2015-12-31 | $5,640,298 |
Value of net income/loss | 2015-12-31 | $-63,627,713 |
Value of net assets at end of year (total assets less liabilities) | 2015-12-31 | $3,138,444,470 |
Value of net assets at beginning of year (total assets less liabilities) | 2015-12-31 | $2,811,906,499 |
Were any loans by the plan or fixed income obligations due to the plan in default | 2015-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2015-12-31 | No |
Assets. partnership/joint venture interests at end of year | 2015-12-31 | $822,452,018 |
Assets. partnership/joint venture interests at beginning of year | 2015-12-31 | $13,468,029 |
Investment advisory and management fees | 2015-12-31 | $3,647,585 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2015-12-31 | $223,102,101 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2015-12-31 | $305,802,708 |
Interest earned on other investments | 2015-12-31 | $3,362,688 |
Income. Interest from US Government securities | 2015-12-31 | $1,514,534 |
Income. Interest from corporate debt instruments | 2015-12-31 | $6,910,284 |
Value of interest in common/collective trusts at end of year | 2015-12-31 | $991,810,562 |
Value of interest in common/collective trusts at beginning of year | 2015-12-31 | $984,474,486 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2015-12-31 | $7,884,741 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2015-12-31 | $0 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2015-12-31 | $0 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2015-12-31 | $33,356 |
Assets. Value of investments in 103.12 investment entities at end of year | 2015-12-31 | $177,276,101 |
Assets. Value of investments in 103.12 investment entities at beginning of year | 2015-12-31 | $274,347,432 |
Asset value of US Government securities at end of year | 2015-12-31 | $53,158,846 |
Asset value of US Government securities at beginning of year | 2015-12-31 | $50,464,168 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2015-12-31 | $-17,466,394 |
Net investment gain or loss from common/collective trusts | 2015-12-31 | $-36,141,610 |
Net gain/loss from 103.12 investment entities | 2015-12-31 | $10,087,286 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2015-12-31 | Yes |
Income. Dividends from preferred stock | 2015-12-31 | $49,019 |
Income. Dividends from common stock | 2015-12-31 | $7,385,711 |
Asset. Corporate debt instrument preferred debt at end of year | 2015-12-31 | $21,167,857 |
Asset. Corporate debt instrument preferred debt at beginning of year | 2015-12-31 | $61,489,428 |
Asset. Corporate debt instrument debt (other) at end of year | 2015-12-31 | $164,051,944 |
Asset. Corporate debt instrument debt (other) at beginning of year | 2015-12-31 | $38,556,370 |
Assets. Corporate common stocks other than exployer securities at end of year | 2015-12-31 | $654,750,353 |
Assets. Corporate common stocks other than exployer securities at beginning of year | 2015-12-31 | $533,842,738 |
Did the plan have assets held for investment | 2015-12-31 | Yes |
Aggregate proceeds on sale of assets | 2015-12-31 | $545,535,642 |
Aggregate carrying amount (costs) on sale of assets | 2015-12-31 | $543,461,796 |
2014 : ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2014 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2014-12-31 | $76,146,726 |
Total unrealized appreciation/depreciation of assets | 2014-12-31 | $76,146,726 |
Total transfer of assets to this plan | 2014-12-31 | $1,137,327,838 |
Total transfer of assets from this plan | 2014-12-31 | $916,767,657 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2014-12-31 | $22,677,313 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2014-12-31 | $10,431,140 |
Total income from all sources (including contributions) | 2014-12-31 | $163,384,129 |
Total loss/gain on sale of assets | 2014-12-31 | $10,752,806 |
Total of all expenses incurred | 2014-12-31 | $9,638,477 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2014-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2014-12-31 | $0 |
Value of total assets at end of year | 2014-12-31 | $2,834,583,812 |
Value of total assets at beginning of year | 2014-12-31 | $2,448,031,806 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2014-12-31 | $9,638,477 |
Total interest from all sources | 2014-12-31 | $3,033,842 |
Total dividends received (eg from common stock, registered investment company shares) | 2014-12-31 | $14,590,418 |
Total dividends received from registered investment company shares (eg mutual funds) | 2014-12-31 | $9,426,359 |
Administrative expenses professional fees incurred | 2014-12-31 | $13,957 |
Assets. Corporate prefeered stocks other than exployer securities at end of year | 2014-12-31 | $0 |
Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2014-12-31 | $13,407 |
Were there any nonexempt tranactions with any party-in-interest | 2014-12-31 | No |
Assets. Other investments not covered elsewhere at end of year | 2014-12-31 | $533,777,805 |
Assets. Other investments not covered elsewhere at beginning of year | 2014-12-31 | $506,794,019 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2014-12-31 | $38,360,648 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2014-12-31 | $20,052,667 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2014-12-31 | $22,677,313 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2014-12-31 | $10,431,140 |
Other income not declared elsewhere | 2014-12-31 | $4,280,658 |
Administrative expenses (other) incurred | 2014-12-31 | $4,623,832 |
Value of net income/loss | 2014-12-31 | $153,745,652 |
Value of net assets at end of year (total assets less liabilities) | 2014-12-31 | $2,811,906,499 |
Value of net assets at beginning of year (total assets less liabilities) | 2014-12-31 | $2,437,600,666 |
Were any loans by the plan or fixed income obligations due to the plan in default | 2014-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2014-12-31 | No |
Assets. partnership/joint venture interests at end of year | 2014-12-31 | $13,468,029 |
Assets. partnership/joint venture interests at beginning of year | 2014-12-31 | $19,361,230 |
Investment advisory and management fees | 2014-12-31 | $5,000,688 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2014-12-31 | $305,802,708 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2014-12-31 | $340,749,681 |
Income. Interest from US Government securities | 2014-12-31 | $1,456,022 |
Income. Interest from corporate debt instruments | 2014-12-31 | $1,577,820 |
Value of interest in common/collective trusts at end of year | 2014-12-31 | $984,474,486 |
Value of interest in common/collective trusts at beginning of year | 2014-12-31 | $705,968,890 |
Assets. Value of investments in 103.12 investment entities at end of year | 2014-12-31 | $274,347,432 |
Assets. Value of investments in 103.12 investment entities at beginning of year | 2014-12-31 | $264,168,503 |
Asset value of US Government securities at end of year | 2014-12-31 | $50,464,168 |
Asset value of US Government securities at beginning of year | 2014-12-31 | $80,231,040 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2014-12-31 | $-3,640,969 |
Net investment gain or loss from common/collective trusts | 2014-12-31 | $46,928,530 |
Net gain/loss from 103.12 investment entities | 2014-12-31 | $11,292,118 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2014-12-31 | Yes |
Income. Dividends from common stock | 2014-12-31 | $5,164,059 |
Asset. Corporate debt instrument preferred debt at end of year | 2014-12-31 | $61,489,428 |
Asset. Corporate debt instrument preferred debt at beginning of year | 2014-12-31 | $9 |
Asset. Corporate debt instrument debt (other) at end of year | 2014-12-31 | $38,556,370 |
Asset. Corporate debt instrument debt (other) at beginning of year | 2014-12-31 | $926 |
Assets. Corporate common stocks other than exployer securities at end of year | 2014-12-31 | $533,842,738 |
Assets. Corporate common stocks other than exployer securities at beginning of year | 2014-12-31 | $510,691,434 |
Did the plan have assets held for investment | 2014-12-31 | Yes |
Aggregate proceeds on sale of assets | 2014-12-31 | $476,091,393 |
Aggregate carrying amount (costs) on sale of assets | 2014-12-31 | $465,338,587 |
2013 : ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2013 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2013-12-31 | $158,435,304 |
Total unrealized appreciation/depreciation of assets | 2013-12-31 | $158,435,304 |
Total transfer of assets to this plan | 2013-12-31 | $1,487,883,592 |
Total transfer of assets from this plan | 2013-12-31 | $5,941,151,824 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2013-12-31 | $10,431,140 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2013-12-31 | $5,487,649 |
Total income from all sources (including contributions) | 2013-12-31 | $491,654,986 |
Total loss/gain on sale of assets | 2013-12-31 | $36,899,410 |
Total of all expenses incurred | 2013-12-31 | $7,669,850 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2013-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2013-12-31 | $0 |
Value of total assets at end of year | 2013-12-31 | $2,448,031,806 |
Value of total assets at beginning of year | 2013-12-31 | $6,412,371,411 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2013-12-31 | $7,669,850 |
Total interest from all sources | 2013-12-31 | $38,191 |
Total dividends received (eg from common stock, registered investment company shares) | 2013-12-31 | $11,090,351 |
Total dividends received from registered investment company shares (eg mutual funds) | 2013-12-31 | $7,308,478 |
Administrative expenses professional fees incurred | 2013-12-31 | $6,214 |
Assets. Corporate prefeered stocks other than exployer securities at end of year | 2013-12-31 | $13,407 |
Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2013-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2013-12-31 | No |
Assets. Other investments not covered elsewhere at end of year | 2013-12-31 | $506,794,019 |
Assets. Other investments not covered elsewhere at beginning of year | 2013-12-31 | $994,323,002 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2013-12-31 | $20,052,667 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2013-12-31 | $13,508,911 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2013-12-31 | $10,431,140 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2013-12-31 | $5,487,649 |
Other income not declared elsewhere | 2013-12-31 | $3,187,443 |
Administrative expenses (other) incurred | 2013-12-31 | $3,452,995 |
Value of net income/loss | 2013-12-31 | $483,985,136 |
Value of net assets at end of year (total assets less liabilities) | 2013-12-31 | $2,437,600,666 |
Value of net assets at beginning of year (total assets less liabilities) | 2013-12-31 | $6,406,883,762 |
Were any loans by the plan or fixed income obligations due to the plan in default | 2013-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2013-12-31 | No |
Assets. partnership/joint venture interests at end of year | 2013-12-31 | $19,361,230 |
Assets. partnership/joint venture interests at beginning of year | 2013-12-31 | $20,899,651 |
Investment advisory and management fees | 2013-12-31 | $4,210,641 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2013-12-31 | $340,749,681 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2013-12-31 | $893,233,834 |
Income. Interest from US Government securities | 2013-12-31 | $38,191 |
Value of interest in common/collective trusts at end of year | 2013-12-31 | $705,968,890 |
Value of interest in common/collective trusts at beginning of year | 2013-12-31 | $2,761,133,416 |
Assets. Value of investments in 103.12 investment entities at end of year | 2013-12-31 | $264,168,503 |
Assets. Value of investments in 103.12 investment entities at beginning of year | 2013-12-31 | $586,597,659 |
Asset value of US Government securities at end of year | 2013-12-31 | $80,231,040 |
Asset value of US Government securities at beginning of year | 2013-12-31 | $278,957,320 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2013-12-31 | $19,492,989 |
Net investment gain or loss from common/collective trusts | 2013-12-31 | $243,315,121 |
Net gain/loss from 103.12 investment entities | 2013-12-31 | $19,196,177 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2013-12-31 | Yes |
Income. Dividends from common stock | 2013-12-31 | $3,781,873 |
Asset. Corporate debt instrument preferred debt at end of year | 2013-12-31 | $9 |
Asset. Corporate debt instrument preferred debt at beginning of year | 2013-12-31 | $10 |
Asset. Corporate debt instrument debt (other) at end of year | 2013-12-31 | $926 |
Asset. Corporate debt instrument debt (other) at beginning of year | 2013-12-31 | $938 |
Assets. Corporate common stocks other than exployer securities at end of year | 2013-12-31 | $510,691,434 |
Assets. Corporate common stocks other than exployer securities at beginning of year | 2013-12-31 | $863,716,670 |
Did the plan have assets held for investment | 2013-12-31 | Yes |
Aggregate proceeds on sale of assets | 2013-12-31 | $3,940,793,295 |
Aggregate carrying amount (costs) on sale of assets | 2013-12-31 | $3,903,893,885 |
2012 : ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2012 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2012-12-31 | $172,988,104 |
Total unrealized appreciation/depreciation of assets | 2012-12-31 | $172,988,104 |
Total transfer of assets to this plan | 2012-12-31 | $1,295,674,411 |
Total transfer of assets from this plan | 2012-12-31 | $1,308,396,201 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2012-12-31 | $5,487,649 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2012-12-31 | $260,905,390 |
Total income from all sources (including contributions) | 2012-12-31 | $714,043,868 |
Total loss/gain on sale of assets | 2012-12-31 | $52,807,762 |
Total of all expenses incurred | 2012-12-31 | $12,966,994 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2012-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2012-12-31 | $0 |
Value of total assets at end of year | 2012-12-31 | $6,412,371,411 |
Value of total assets at beginning of year | 2012-12-31 | $5,979,434,068 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2012-12-31 | $12,966,994 |
Total interest from all sources | 2012-12-31 | $9,342,178 |
Total dividends received (eg from common stock, registered investment company shares) | 2012-12-31 | $32,507,332 |
Total dividends received from registered investment company shares (eg mutual funds) | 2012-12-31 | $21,253,828 |
Were there any nonexempt tranactions with any party-in-interest | 2012-12-31 | No |
Assets. Other investments not covered elsewhere at end of year | 2012-12-31 | $994,323,002 |
Assets. Other investments not covered elsewhere at beginning of year | 2012-12-31 | $854,541,240 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2012-12-31 | $13,508,911 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2012-12-31 | $245,533,309 |
Other income not declared elsewhere | 2012-12-31 | $321,710 |
Administrative expenses (other) incurred | 2012-12-31 | $6,183,961 |
Liabilities. Value of operating payables at end of year | 2012-12-31 | $5,487,649 |
Liabilities. Value of operating payables at beginning of year | 2012-12-31 | $260,905,390 |
Value of net income/loss | 2012-12-31 | $701,076,874 |
Value of net assets at end of year (total assets less liabilities) | 2012-12-31 | $6,406,883,762 |
Value of net assets at beginning of year (total assets less liabilities) | 2012-12-31 | $5,718,528,678 |
Were any loans by the plan or fixed income obligations due to the plan in default | 2012-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2012-12-31 | No |
Assets. partnership/joint venture interests at end of year | 2012-12-31 | $20,899,651 |
Assets. partnership/joint venture interests at beginning of year | 2012-12-31 | $13,677,679 |
Investment advisory and management fees | 2012-12-31 | $6,783,033 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2012-12-31 | $893,233,834 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2012-12-31 | $476,709,507 |
Interest earned on other investments | 2012-12-31 | $108,729 |
Income. Interest from US Government securities | 2012-12-31 | $7,091,324 |
Income. Interest from corporate debt instruments | 2012-12-31 | $2,142,125 |
Value of interest in common/collective trusts at end of year | 2012-12-31 | $2,761,133,416 |
Value of interest in common/collective trusts at beginning of year | 2012-12-31 | $2,516,848,405 |
Assets. Value of investments in 103.12 investment entities at end of year | 2012-12-31 | $586,597,659 |
Assets. Value of investments in 103.12 investment entities at beginning of year | 2012-12-31 | $543,463,929 |
Asset value of US Government securities at end of year | 2012-12-31 | $278,957,320 |
Asset value of US Government securities at beginning of year | 2012-12-31 | $485,916,117 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2012-12-31 | $49,391,640 |
Net investment gain or loss from common/collective trusts | 2012-12-31 | $353,551,414 |
Net gain/loss from 103.12 investment entities | 2012-12-31 | $43,133,728 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2012-12-31 | Yes |
Income. Dividends from common stock | 2012-12-31 | $11,253,504 |
Asset. Corporate debt instrument preferred debt at end of year | 2012-12-31 | $10 |
Asset. Corporate debt instrument preferred debt at beginning of year | 2012-12-31 | $44,252,780 |
Asset. Corporate debt instrument debt (other) at end of year | 2012-12-31 | $938 |
Asset. Corporate debt instrument debt (other) at beginning of year | 2012-12-31 | $41,472,865 |
Assets. Corporate common stocks other than exployer securities at end of year | 2012-12-31 | $863,716,670 |
Assets. Corporate common stocks other than exployer securities at beginning of year | 2012-12-31 | $757,018,237 |
Did the plan have assets held for investment | 2012-12-31 | Yes |
Aggregate proceeds on sale of assets | 2012-12-31 | $3,883,444,732 |
Aggregate carrying amount (costs) on sale of assets | 2012-12-31 | $3,830,636,970 |
2011 : ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2011 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2011-12-31 | $484,945,769 |
Total unrealized appreciation/depreciation of assets | 2011-12-31 | $484,945,769 |
Total transfer of assets to this plan | 2011-12-31 | $749,583,249 |
Total transfer of assets from this plan | 2011-12-31 | $725,373,243 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2011-12-31 | $260,905,390 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2011-12-31 | $599,041,544 |
Total income from all sources (including contributions) | 2011-12-31 | $21,543,472 |
Total loss/gain on sale of assets | 2011-12-31 | $-487,718,046 |
Total of all expenses incurred | 2011-12-31 | $11,298,784 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2011-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2011-12-31 | $0 |
Value of total assets at end of year | 2011-12-31 | $5,979,434,068 |
Value of total assets at beginning of year | 2011-12-31 | $6,283,115,528 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2011-12-31 | $11,298,784 |
Total interest from all sources | 2011-12-31 | $12,935,739 |
Total dividends received (eg from common stock, registered investment company shares) | 2011-12-31 | $19,075,604 |
Total dividends received from registered investment company shares (eg mutual funds) | 2011-12-31 | $10,652,671 |
Were there any nonexempt tranactions with any party-in-interest | 2011-12-31 | No |
Assets. Other investments not covered elsewhere at end of year | 2011-12-31 | $854,541,240 |
Assets. Other investments not covered elsewhere at beginning of year | 2011-12-31 | $832,097,515 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2011-12-31 | $245,533,309 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2011-12-31 | $529,763,160 |
Other income not declared elsewhere | 2011-12-31 | $106,890 |
Liabilities. Value of operating payables at end of year | 2011-12-31 | $260,905,390 |
Liabilities. Value of operating payables at beginning of year | 2011-12-31 | $599,041,544 |
Value of net income/loss | 2011-12-31 | $10,244,688 |
Value of net assets at end of year (total assets less liabilities) | 2011-12-31 | $5,718,528,678 |
Value of net assets at beginning of year (total assets less liabilities) | 2011-12-31 | $5,684,073,984 |
Were any loans by the plan or fixed income obligations due to the plan in default | 2011-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2011-12-31 | No |
Assets. partnership/joint venture interests at end of year | 2011-12-31 | $13,677,679 |
Assets. partnership/joint venture interests at beginning of year | 2011-12-31 | $11,402,502 |
Investment advisory and management fees | 2011-12-31 | $11,298,784 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2011-12-31 | $476,709,507 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2011-12-31 | $516,742,181 |
Interest earned on other investments | 2011-12-31 | $166,954 |
Income. Interest from US Government securities | 2011-12-31 | $8,449,986 |
Income. Interest from corporate debt instruments | 2011-12-31 | $4,318,799 |
Value of interest in common/collective trusts at end of year | 2011-12-31 | $2,516,848,405 |
Value of interest in common/collective trusts at beginning of year | 2011-12-31 | $2,652,514,152 |
Assets. Value of investments in 103.12 investment entities at end of year | 2011-12-31 | $543,463,929 |
Assets. Value of investments in 103.12 investment entities at beginning of year | 2011-12-31 | $391,827,176 |
Asset value of US Government securities at end of year | 2011-12-31 | $485,916,117 |
Asset value of US Government securities at beginning of year | 2011-12-31 | $433,154,017 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2011-12-31 | $-46,130,161 |
Net investment gain or loss from common/collective trusts | 2011-12-31 | $-38,000,296 |
Net gain/loss from 103.12 investment entities | 2011-12-31 | $76,327,973 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2011-12-31 | Yes |
Income. Dividends from common stock | 2011-12-31 | $8,422,933 |
Asset. Corporate debt instrument preferred debt at end of year | 2011-12-31 | $44,252,780 |
Asset. Corporate debt instrument preferred debt at beginning of year | 2011-12-31 | $46,986,599 |
Asset. Corporate debt instrument debt (other) at end of year | 2011-12-31 | $41,472,865 |
Asset. Corporate debt instrument debt (other) at beginning of year | 2011-12-31 | $38,480,181 |
Assets. Corporate common stocks other than exployer securities at end of year | 2011-12-31 | $757,018,237 |
Assets. Corporate common stocks other than exployer securities at beginning of year | 2011-12-31 | $830,148,045 |
Did the plan have assets held for investment | 2011-12-31 | Yes |
Aggregate proceeds on sale of assets | 2011-12-31 | $3,423,312,692 |
Aggregate carrying amount (costs) on sale of assets | 2011-12-31 | $3,911,030,738 |
2010 : ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2010 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2010-12-31 | $35,435,177 |
Total unrealized appreciation/depreciation of assets | 2010-12-31 | $35,435,177 |
Total transfer of assets to this plan | 2010-12-31 | $5,568,747,167 |
Total transfer of assets from this plan | 2010-12-31 | $70,464,759 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2010-12-31 | $599,041,544 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2010-12-31 | $0 |
Total income from all sources (including contributions) | 2010-12-31 | $188,719,802 |
Total loss/gain on sale of assets | 2010-12-31 | $1,156,709 |
Total of all expenses incurred | 2010-12-31 | $2,928,226 |
Value of total assets at end of year | 2010-12-31 | $6,283,115,528 |
Value of total assets at beginning of year | 2010-12-31 | $0 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2010-12-31 | $2,928,226 |
Total interest from all sources | 2010-12-31 | $4,760,380 |
Total dividends received (eg from common stock, registered investment company shares) | 2010-12-31 | $10,001,057 |
Total dividends received from registered investment company shares (eg mutual funds) | 2010-12-31 | $7,999,638 |
Were there any nonexempt tranactions with any party-in-interest | 2010-12-31 | No |
Assets. Other investments not covered elsewhere at end of year | 2010-12-31 | $832,097,514 |
Assets. Other investments not covered elsewhere at beginning of year | 2010-12-31 | $0 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2010-12-31 | $529,763,160 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2010-12-31 | $0 |
Other income not declared elsewhere | 2010-12-31 | $17,270,766 |
Liabilities. Value of operating payables at end of year | 2010-12-31 | $599,041,544 |
Liabilities. Value of operating payables at beginning of year | 2010-12-31 | $0 |
Value of net income/loss | 2010-12-31 | $185,791,576 |
Value of net assets at end of year (total assets less liabilities) | 2010-12-31 | $5,684,073,984 |
Value of net assets at beginning of year (total assets less liabilities) | 2010-12-31 | $0 |
Were any loans by the plan or fixed income obligations due to the plan in default | 2010-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2010-12-31 | No |
Assets. partnership/joint venture interests at end of year | 2010-12-31 | $11,402,502 |
Assets. partnership/joint venture interests at beginning of year | 2010-12-31 | $0 |
Investment advisory and management fees | 2010-12-31 | $2,928,226 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2010-12-31 | $516,742,181 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2010-12-31 | $0 |
Interest earned on other investments | 2010-12-31 | $2,671,735 |
Income. Interest from US Government securities | 2010-12-31 | $1,392,168 |
Income. Interest from corporate debt instruments | 2010-12-31 | $696,477 |
Value of interest in common/collective trusts at end of year | 2010-12-31 | $2,652,514,153 |
Value of interest in common/collective trusts at beginning of year | 2010-12-31 | $0 |
Assets. Value of investments in 103.12 investment entities at end of year | 2010-12-31 | $391,827,176 |
Assets. Value of investments in 103.12 investment entities at beginning of year | 2010-12-31 | $0 |
Asset value of US Government securities at end of year | 2010-12-31 | $433,154,017 |
Asset value of US Government securities at beginning of year | 2010-12-31 | $0 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2010-12-31 | $15,828,895 |
Net investment gain or loss from common/collective trusts | 2010-12-31 | $102,646,035 |
Net gain/loss from 103.12 investment entities | 2010-12-31 | $1,620,783 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2010-12-31 | Yes |
Income. Dividends from common stock | 2010-12-31 | $2,001,419 |
Asset. Corporate debt instrument preferred debt at end of year | 2010-12-31 | $46,986,599 |
Asset. Corporate debt instrument preferred debt at beginning of year | 2010-12-31 | $0 |
Asset. Corporate debt instrument debt (other) at end of year | 2010-12-31 | $38,480,181 |
Asset. Corporate debt instrument debt (other) at beginning of year | 2010-12-31 | $0 |
Assets. Corporate common stocks other than exployer securities at end of year | 2010-12-31 | $830,148,045 |
Assets. Corporate common stocks other than exployer securities at beginning of year | 2010-12-31 | $0 |
Did the plan have assets held for investment | 2010-12-31 | Yes |
Aggregate proceeds on sale of assets | 2010-12-31 | $630,163,303 |
Aggregate carrying amount (costs) on sale of assets | 2010-12-31 | $629,006,594 |
2023: ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2023 form 5500 responses | ||
---|---|---|
2023-01-01 | Type of plan entity | DFE (Diect Filing Entity) |
2023-01-01 | Submission has been amended | No |
2023-01-01 | This submission is the final filing | No |
2023-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2023-01-01 | Plan is a collectively bargained plan | No |
2022: ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2022 form 5500 responses | ||
2022-01-01 | Type of plan entity | DFE (Diect Filing Entity) |
2022-01-01 | Submission has been amended | No |
2022-01-01 | This submission is the final filing | No |
2022-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2022-01-01 | Plan is a collectively bargained plan | No |
2021: ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2021 form 5500 responses | ||
2021-01-01 | Type of plan entity | DFE (Diect Filing Entity) |
2021-01-01 | Submission has been amended | No |
2021-01-01 | This submission is the final filing | No |
2021-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2021-01-01 | Plan is a collectively bargained plan | No |
2020: ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2020 form 5500 responses | ||
2020-01-01 | Type of plan entity | DFE (Diect Filing Entity) |
2020-01-01 | Submission has been amended | No |
2020-01-01 | This submission is the final filing | No |
2020-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2020-01-01 | Plan is a collectively bargained plan | No |
2019: ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2019 form 5500 responses | ||
2019-01-01 | Type of plan entity | DFE (Diect Filing Entity) |
2019-01-01 | Submission has been amended | No |
2019-01-01 | This submission is the final filing | No |
2019-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2019-01-01 | Plan is a collectively bargained plan | No |
2018: ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2018 form 5500 responses | ||
2018-01-01 | Type of plan entity | DFE (Diect Filing Entity) |
2018-01-01 | Submission has been amended | No |
2018-01-01 | This submission is the final filing | No |
2018-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2018-01-01 | Plan is a collectively bargained plan | No |
2017: ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2017 form 5500 responses | ||
2017-01-01 | Type of plan entity | DFE (Diect Filing Entity) |
2017-01-01 | Submission has been amended | No |
2017-01-01 | This submission is the final filing | No |
2017-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2017-01-01 | Plan is a collectively bargained plan | No |
2016: ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2016 form 5500 responses | ||
2016-01-01 | Type of plan entity | DFE (Diect Filing Entity) |
2016-01-01 | Submission has been amended | No |
2016-01-01 | This submission is the final filing | No |
2016-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2016-01-01 | Plan is a collectively bargained plan | No |
2015: ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2015 form 5500 responses | ||
2015-01-01 | Type of plan entity | DFE (Diect Filing Entity) |
2015-01-01 | Submission has been amended | No |
2015-01-01 | This submission is the final filing | No |
2015-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2015-01-01 | Plan is a collectively bargained plan | No |
2014: ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2014 form 5500 responses | ||
2014-01-01 | Type of plan entity | DFE (Diect Filing Entity) |
2014-01-01 | Submission has been amended | No |
2014-01-01 | This submission is the final filing | No |
2014-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2014-01-01 | Plan is a collectively bargained plan | No |
2013: ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2013 form 5500 responses | ||
2013-01-01 | Type of plan entity | DFE (Diect Filing Entity) |
2013-01-01 | Submission has been amended | No |
2013-01-01 | This submission is the final filing | No |
2013-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2013-01-01 | Plan is a collectively bargained plan | No |
2012: ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2012 form 5500 responses | ||
2012-01-01 | Type of plan entity | DFE (Diect Filing Entity) |
2012-01-01 | Submission has been amended | No |
2012-01-01 | This submission is the final filing | No |
2012-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2012-01-01 | Plan is a collectively bargained plan | No |
2011: ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2011 form 5500 responses | ||
2011-01-01 | Type of plan entity | DFE (Diect Filing Entity) |
2011-01-01 | Submission has been amended | No |
2011-01-01 | This submission is the final filing | No |
2011-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2011-01-01 | Plan is a collectively bargained plan | No |
2010: ABBOTT LABORATORIES ANNUITY RETIREMENT TRUST 2010 form 5500 responses | ||
2010-10-29 | Type of plan entity | DFE (Diect Filing Entity) |
2010-10-29 | First time form 5500 has been submitted | Yes |
2010-10-29 | Submission has been amended | No |
2010-10-29 | This submission is the final filing | No |
2010-10-29 | This return/report is a short plan year return/report (less than 12 months) | Yes |
2010-10-29 | Plan is a collectively bargained plan | No |